NYMCIA STATEMENT ON CANNABIS INSIDER’S INVESTIGATIVE REPORT

Sept. 21, 2023

THE FOLLOWING STATEMENT IS ATTRIBUTABLE TO THE NEW YORK MEDICAL CANNABIS INDUSTRY ASSOCIATION: 

“Yesterday’s investigative report by Cannabis Insider underscores the importance of having robust cannabis lab testing protocols and procedures. For nearly a decade, New York’s medical cannabis operators have complied with some of the strictest lab testing standards ever undertaken in the cannabis industry. While daunting in the early years, New York’s medical cannabis quality assurance rigor resulted in operators who learned how to formulate cannabis products with greater precision than that required for traditional pharmaceutical manufacturing in the United States. 

New York’s medical operators look forward to continuing their proven track record of supplying safe product and extending that to all New Yorkers—medical patients and adult-use consumers alike—with products confirmed to be free of bacteria, mold, heavy metals, yeast, microbes, and other contaminants.”

###